Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D V Spicer

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Endocrine-Related Cancer|July 21, 2000
Hormonal contraception and chemoprevention of female cancersM C Pike, D V Spicer
Breast Cancer Research and Treatment|November 1, 1993
Breast cancer prevention through modulation of endogenous hormonesD V Spicer, M C Pike
Lancet (London, England)|July 17, 1993
Hormone replacement after breast cancerD V Spicer, M C Pike
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
The prevention of breast cancer through reduced ovarian steroid exposureD V Spicer, M C Pike
Breast Cancer Research : BCR|March 16, 2001
Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonistsD V Spicer, M C Pike
Journal of the National Cancer Institute. Monographs|January 1, 1994
Sex steroids and breast cancer preventionD V Spicer, M C Pike
Journal of Cellular Biochemistry. Supplement|January 1, 1993
The chemoprevention of breast cancer by reducing sex steroid exposure: perspectives from epidemiologyM C Pike, D V Spicer
Contraception|September 1, 1991
GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancerD V Spicer, D Shoupe, M C Pike
Lancet (London, England)|March 13, 1993
Tamoxifen and preventionG Ursin, D V Spicer, M C Pike
Seminars in Oncology|April 1, 1995
Oral vinorelbine (Navelbine) in the treatment of advanced breast cancerE P Winer, L Chu, D V Spicer
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Endocrine-Related Cancer|July 21, 2000
Hormonal contraception and chemoprevention of female cancersM C Pike, D V Spicer
Breast Cancer Research and Treatment|November 1, 1993
Breast cancer prevention through modulation of endogenous hormonesD V Spicer, M C Pike
Lancet (London, England)|July 17, 1993
Hormone replacement after breast cancerD V Spicer, M C Pike
Acta Oncologica (Stockholm, Sweden)|January 1, 1992
The prevention of breast cancer through reduced ovarian steroid exposureD V Spicer, M C Pike
Breast Cancer Research : BCR|March 16, 2001
Future possibilities in the prevention of breast cancer: luteinizing hormone-releasing hormone agonistsD V Spicer, M C Pike
Journal of the National Cancer Institute. Monographs|January 1, 1994
Sex steroids and breast cancer preventionD V Spicer, M C Pike
Journal of Cellular Biochemistry. Supplement|January 1, 1993
The chemoprevention of breast cancer by reducing sex steroid exposure: perspectives from epidemiologyM C Pike, D V Spicer
Contraception|September 1, 1991
GnRH agonists as contraceptive agents: predicted significantly reduced risk of breast cancerD V Spicer, D Shoupe, M C Pike
Lancet (London, England)|March 13, 1993
Tamoxifen and preventionG Ursin, D V Spicer, M C Pike
Seminars in Oncology|April 1, 1995
Oral vinorelbine (Navelbine) in the treatment of advanced breast cancerE P Winer, L Chu, D V Spicer
Pageof 4